Key result
A meta-analysis of genetic data identified 15 novel genome-wide significant loci associated with coronary artery disease, expanding known risk loci by 20% and highlighting genes involved in angiogenesis.
Why the study?
Do specific genetic variants increase the risk of coronary artery disease and other cardiovascular phenotypes in the general population?
Meta-Analysis (n=278,915)
Yes
Do specific genetic variants increase the risk of coronary artery disease and other cardiovascular phenotypes in the general population?
The identification of 15 novel genetic loci for CAD expands the understanding of its genetic basis and highlights pathways like angiogenesis as potential therapeutic targets.
Answers are grounded in this paper and cite their sources.
Highlights angiogenesis as a potential therapeutic target for CAD; extends the known genetic architecture while leaving open the.
Coronary artery disease (CAD) is the major cause of morbidity and mortality in the world. Identification of novel genetic determinants may provide new opportunities for developing innovative strategies to predict, prevent and treat CAD. Therefore, we meta-analyzed independent genetic variants passing P <× 10−5 in CARDIoGRAMplusC4D with novel data made available by UK Biobank. Of the 161 genetic variants studied, 71 reached genome wide significance (p < 5 × 10−8) including 15 novel loci. These novel loci include multiple genes that are involved in angiogenesis (TGFB1, ITGB5, CDH13 and RHOA) and 2 independent variants in the TGFB1 locus. We also identified SGEF as a candidate gene in one of the novel CAD loci. SGEF was previously suggested as a therapeutic target based on mouse studies. The genetic risk score of CAD predicted recurrent CAD events and cardiovascular mortality. We also identified significant genetic correlations between CAD and other cardiovascular conditions, including heart failure and atrial fibrillation. In conclusion, we substantially increased the number of loci convincingly associated with CAD and provide additional biological and clinical insights.
No takes yet. Share an insight, caveat, or question.
Verweij et al. (2017) conducted a meta-analysis in Coronary artery disease (n=278,915). Genetic risk loci vs. Non-carriers / reference alleles was evaluated on Genome-wide significant association with coronary artery disease (p=< 5 × 10^-8). A meta-analysis of genetic data identified 15 novel genome-wide significant loci associated with coronary artery disease, expanding known risk loci by 20% and highlighting genes involved in angiogenesis.
Synapse has enriched 10 related papers. Consider them for comparative context: